Skip to main content

Global Tamoxifen Market to Reach Worth USD 683.7 Mn by 2022: Emerging Countries to Witness Higher Demand

According to the latest report published by Credence Research, Inc. “Tamoxifen Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the tamoxifen market was valued at USD 675.7 Mn in 2015, and is expected to reach USD 683.6 Mn by 2022, expanding at a CAGR of 0.07% from 2016 to 2022.
Browse the full report Tamoxifen: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at http://www.credenceresearch.com/report/tamoxifen-market
Market Insights
Tamoxifen is the oldest and among the most prescribed selective estrogen receptor modulator for breast cancer treatment and management. Tamoxifen is approved for early stage, hormone receptor positive breast cancer in men and women, after surgery or chemotherapy to reduce recurrence risk, and for management of advanced stage or metastatic hormone-receptor positive breast cancer. Women at high risk of developing breast cancer also use Tamoxifen. Tamoxifen is at the maturity stage of product life cycle and is anticipated to experience decline in market growth in the light of introduction of advanced breast cancer management drugs.
This report analyzes the geographical distribution of tamoxifen market in North America, Europe, Asia-Pacific and Rest of the World markets. Currently, North America is the largest market for tamoxifen drugs and it is anticipated that the lead of this region will continue through 2022. Large pool of breast cancer patients, high awareness for breast cancer screening and prevention, well-structured reimbursement scenario and large pool of breast cancer patients. Asia-Pacific and Rest of the World markets will experience the fastest CAGR during 2016-2022. Improving awareness in Middle East and Africa, high incidence of late stage breast cancer in these regions and rapid development of healthcare infrastructure are the prime drivers of Rest of the World market.
Proven long-term efficiency of hormone therapy for management and control of breast cancer across various stages of treatment, in geriatric patients that cannot opt for surgery, and late-stage and recurrent breast cancer, and widespread use of tamoxifen as adjuvant therapy are the prime factors driving the demand for tamoxifen. Growth of tamoxifen-resistant cancer and growing awareness about the drug inducing endometrial cancer may restrain the market growth. Growing application of tamoxifen in treatment of conditions such as McCune-Albright syndrome, infertility, gynecomastia, bipolar disorder, angiogenesis and Riedel’s thyroiditis, and its use in research studies involving gene expression serve as future avenues for the growth of this market.
The global tamoxifen market is moderately competitive with AstraZaneca, Teva Pharmaceutical Industries, Allergan, Mylan, Apotex and Midatech the known players. Anticipated merger of Teva with Allergan is expected to bring a shift in market competition.
ToC
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
Chapter 3 Tamoxifen: Market Dynamics and Outlook
3.1 Introduction
3.2 Breast Cancer: Key Statistics
3.3 Major Events Assessment
3.4 Market Dynamics
3.4.1 Drivers
3.4.1.1 Advantages of Hormone Therapy Across Different Stages of Treatment
3.4.1.2 Widespread use as Adjuvant and Neo-Adjuvant Therapy
3.4.2 Challenges
3.4.2.1 Growth in Tamoxifen-Resistant Breast Cancer
3.4.3 Opportunities
3.4.3.1 Alternative uses of Tamoxifen
3.5 Attractive Investment Proposition................
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290
 

Comments

Popular posts from this blog

Algae Products Market Key Growth Factors and Industry Analysis 2023: Credence Research

According to a new market report published by Credence Research “ Algae Products Market  - Growth, Future Prospects, Competitive Analysis, and Forecast 2016 - 2023,” the algae products market is expected to reach US$ 44.7 Bn by 2023, expanding at a CAGR of more than 5.0% from 2016 to 2023. Browse the full report at  http://www.credenceresearch.com/report/algae-products-market Market Insights: Algae are a diverse group of photosynthetic organisms which are not closely related and hence are known to be polyphyletic. They are plats which range from microalgae to macro algae. Algae are grown using water resources such as sea and waste water which are not suitable for growing agricultural crops. Microalgae grow using sunlight i.e. photosynthesis, by converting sunlight, CO2 and nutrients such as phosphorus and nitrogen into biomass. This growth is also known as autotrophic growth. Some algae can grow in the dark using sugar starch or by combining both the growth modes. Based on applica

Artificial Intelligence Market: Industry Analysis Size, Share, Growth, Trends, Opportunities and Forecast 2016 To 2025 – Credence Research

According to a new market research report published by Credence Research “ Artificial Intelligence Market  (By Technology: Deep Learning, Robotics, Digital Personal Assistant, Querying Method, Neuro-Linguistic Programming and Context-Aware Processing; By End-use Industry: Manufacturing and Processing, BFSI, Oil and Gas, Healthcare, Agriculture, Automotive and Transportation, Retail and Others) - Growth, Future Prospects, and Competitive Landscape, 2017-2025”, artificial intelligence market was valued at US$ 1.36 Bn in 2016 and is expected to grow at a CAGR of 52% during the forecast period from 2017 to 2025. The complete report is available at  http://www.credenceresearch.com/report/artificial-intelligence-market Market Insights Artificial intelligence can be defined as the technology used to create intelligent computing system. The systems equipped with artificial intelligence do not require constant human intervention or supervision to carry out the designated process. A syst

Global Audiology Devices Market Size, Share, Growth, Outlook and Forecast to 2023: Credence Research

The latest market report published by Credence Research, Inc. “ Global Audiology Devices Market  - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2023,” the audiology devices market was valued at USD 8,285.6 Mn in 2015, and is expected to reach USD 12,715.3 Mn by 2023, expanding at a CAGR of (5.4%) from 2016 to 2023. Browse the full report Audiology Devices Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2023 at  http://www.credenceresearch.com/report/audiology-devices-market Market Insights Increasing base of aging population, mounting prevalence of hearing loss, rising patient’s awareness and favorable reimbursement policies in developed countries are the key factors assisting the growth of audiology devices market. Hearing aids was the leading product segment of this market due to rising application rate of these devices along with the introduction of advanced and novel digital technology and aesthetically attractiv